Dynamic Benchmarks
We provide data visualizations into the competitive landscape.
Dynamic Benchmarks puts you in the driver’s seat to take the lead in benchmark analysis to enhance existing processes.
Find the Answers You Need to Inform Your Decision-Making
Data spans back to 1990 and includes clinical programs based on industry-led, FDA-tracked interventional studies.
What are the historical success rates of past assets?
What are the decisions that could lead to different clinical outcomes?
How does my asset compare to historical programs and their clinical trial choices?
How do I better understand the risk drivers for my asset or portfolio?
The Complete Benchmarking Solution You Need
Access to depth and breadth of data based on unique program entity that goes beyond the molecule-indication level.
See both phase-by-phase and path-by-path analyses for better facilitating data-driven decision-making that captures a more comprehensive view of the clinical development path.
Customize your search with dynamic filtering to slice-and-dice data and surface relevant, real-time data.
Motivate Your Business and Challenge the Status Quo
Improve Risk Assessment
View an accurate depiction of historical success rates to gain an in-depth picture of industry dynamics and trends.
Explore the importance of specific clinical development characteristics, such as demographics or regulatory designations to adjust risk predictions.
Calculate precise phase transition success rates and historical approval rates for each development phase to identify key differences between individual therapeutic areas.
Evaluate different development pathways to determine how they have affected the success rates of past programs to inform clinical trial design.
Enhance Strategy
Explore the most promising indications and drug-related attributes to facilitate efficient decision-making for go/no-go decisions.
Understand the recent clinical development landscape and gauge your productivity relative to the market and competitors.
